← Back
$ROIV All transactions

Roivant Sciences Ltd.

A

$ Value

$0

Shares

1,836,547

Price

$0

Filed

Aug 1

Insider

Name

Torti Frank

Title

President and Vant Chair

CIK

0001647805

Roles

Officer

Transaction Details

Transaction Date

2025-07-30

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,836,547

Footnotes

Reflects an award of restricted stock units with respect to Common Shares ("RSUs"), with a vesting commencement date of March 31, 2025, which service-vest (i) 20% on the first anniversary of the vesting commencement date and (ii) in 16 successive equal quarterly installments thereafter, subject to the reporting person's continuous service through each vesting date. | Reflects an award of performance restricted stock units with respect to Common Shares ("PSUs") across six share price hurdle tranches, as follows: $15.00 (14.71% of PSUs); $17.50 (7.35% of PSUs); $20.00 (8.82% of PSUs); $22.50 (11.77% of PSUs); $25.00 (22.06% of PSUs); and $30.00 (35.29% of PSUs). The PSUs will vest tranche-by-tranche on the first date that both the performance condition and the service condition with respect to the applicable tranche of the PSUs has been satisfied. The performance condition will be deemed satisfied for each tranche of PSUs on the first date, during the performance period ending on July 26, 2029, when the Company's trailing 30-day volume weighted average trading price per share for trading days during the performance period exceeds the share price hurdle applicable to such tranche (as specified above). (Continued in footnote 3) | (Continued from footnote 2) The service condition will be deemed satisfied for each tranche of PSUs on the first anniversary of the date on which the performance condition is first satisfied with respect to such tranche, subject to the reporting person's continuous service through such anniversary. In addition, following the satisfaction of the performance condition and service condition and the vesting of any tranche of the PSUs, the common shares underlying the applicable vested tranche of PSUs are subject to a further two-year holding period before such common shares may be sold.

Filing Info

Accession No.

0001140361-25-028453

Form Type

4

Issuer CIK

0001635088

Torti Frank's History

Date Ticker Type Value
2026-04-07 IMVT A $0
2026-04-07 IMVT A $0
2026-03-31 ROIV F $4.4M
2025-07-30 ROIV A $0
2025-07-30 ROIV A $0

Other Insiders at ROIV (90d)

Insider Bought Sold Last
MOMTAZEE JAMES C 2026-04-17
Fitzgerald Meghan $1.9M 2026-03-26
Oren Ilan 2026-04-17
Torti Frank
President and Vant Chair
2026-03-31
Sukhatme Mayukh
President & CIO
2026-03-31
Gline Matthew
CEO
$8.4M 2026-04-16
Venker Eric
President & Immunovant CEO
$5.9M 2026-04-20
Epperly Melissa B, 2026-04-17
Pulik Richard
CFO
2026-04-20
Humes Jennifer
Chief Accounting Officer
$384K 2026-04-20